Today’s AP News (Associated Press) carried a report on the 23andMe DNA company. “Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection.”
Be sure to scroll down the page to read all parts of the article including this important paragraph. “Regeneron said Monday that it will comply with 23andMe’s privacy policies and applicable law, process all customer personal data in accordance with the consents, privacy policies and statements, terms of service, and notices currently in effect and have security controls in place designed to protect such data.”
© 2025, Paula Stuart-Warren. All rights reserved.
Please follow and like us:
